毕索洛尔
參考文獻

↑  . Health Canada. 2009-07-31  [2024-04-19].
↑  . DailyMed.   [2024-04-19].
↑  . DailyMed. 2024-03-06  [2024-04-19]. （原始内容存档于2024-04-19）.
↑  Bühring KU, Sailer H, Faro HP, Leopold G, Pabst J, Garbe A. . Journal of Cardiovascular Pharmacology. 1986, 8 (Suppl 11): S21–S28. PMID 2439794. S2CID 38147937. doi:10.1097/00005344-198511001-00004.
↑  Horikiri Y, Suzuki T, Mizobe M. . Journal of Pharmaceutical Sciences. March 1998, 87 (3): 289–294. PMID 9523980. doi:10.1021/js970316d.
1 2 3  Leopold G. . Journal of Cardiovascular Pharmacology. 1986, 8 (Suppl 11): S16–S20. PMID 2439789. S2CID 25731558. doi:10.1097/00005344-198511001-00003.
1 2 3 4 5 6 7  . The American Society of Health-System Pharmacists.   [2016-12-08]. （原始内容存档于2016-12-21）.
↑  . medicines.org.uk. 2014-02-18  [2016-12-14]. （原始内容存档于2016-12-20）.
↑  . drugs.com.   [2016-12-14]. （原始内容存档于2016-12-21）.
↑  . drugs.com.   [2016-12-14]. （原始内容存档于2016-12-21）.
↑  Fischer J, Ganellin CR. . John Wiley & Sons. 2006: 461. ISBN 9783527607495. （原始内容存档于2017-09-08）.
↑  World Health Organization. . Geneva: World Health Organization. 2023. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.
↑  .   [2013-11-13]. （原始内容存档于2015-02-25）.
↑  . ClinCalc.   [2022-10-07]. （原始内容存档于2021-02-12）.
↑  . ClinCalc.   [2022-10-07]. （原始内容存档于2022-09-28）.
↑  Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD,  et al. . The American Journal of Medicine. October 2014, 127 (10): 939–953. PMID 24927909. doi:10.1016/j.amjmed.2014.05.032 .
↑  CIBIS-II Investigators. . The Lancet. January 1999, 353 (9146): 9–13. S2CID 10083527. doi:10.1016/S0140-6736(98)11181-9. >
↑  Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. . The Cochrane Database of Systematic Reviews. January 2017, 1 (1): CD002003. PMC 5369873 . PMID 28107561. doi:10.1002/14651858.CD002003.pub5.
↑  . heartfoundation-prod.azurewebsites.net.   [2023-05-13]. （原始内容存档于2022-09-13）.
1 2 3  CIBIS Investigators and Committees. . Circulation. October 1994, 90 (4): 1765–1773. PMID 7923660. doi:10.1161/01.cir.90.4.1765 .
1 2 3  Konishi M, Haraguchi G, Kimura S, Inagaki H, Kawabata M, Hachiya H,  et al. . Circulation Journal. June 2010, 74 (6): 1127–1134. PMID 20354334. doi:10.1253/circj.cj-09-0989 .
↑  Castagno D, Jhund PS, McMurray JJ, Lewsey JD, Erdmann E, Zannad F,  et al. . European Journal of Heart Failure. June 2010, 12 (6): 607–616. PMID 20354032. S2CID 205048092. doi:10.1093/eurjhf/hfq038 . hdl:2318/134969 .
1 2 3 4 5 6  Leopold G, Pabst J, Ungethüm W, Bühring KU. . Journal of Clinical Pharmacology. 1986, 26 (8): 616–621. PMID 2878941. S2CID 42159046. doi:10.1002/j.1552-4604.1986.tb02959.x.
1 2 3 4  Leopold G, Ungethüm W, Pabst J, Simane Z, Bühring KU, Wiemann H. . British Journal of Clinical Pharmacology. September 1986, 22 (3): 293–300. PMC 1401121 . PMID 2876722. doi:10.1111/j.1365-2125.1986.tb02890.x.
↑  Hauck RW, Schulz C, Emslander HP, Böhm M. . British Journal of Pharmacology. November 1994, 113 (3): 1043–1049. PMC 1510470 . PMID 7858847. doi:10.1111/j.1476-5381.1994.tb17098.x.
↑  . 2012. PMID 31643790.
1 2  Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B. . Chest. April 2014, 145 (4): 779–786. PMID 24202435. doi:10.1378/chest.13-1235.
1 2  Morales DR, Lipworth BJ, Donnan PT, Jackson C, Guthrie B. . BMC Medicine. January 2017, 15 (1): 18. PMC 5270217 . PMID 28126029. doi:10.1186/s12916-017-0781-0 .
↑  Bennett M, Chang CL, Tatley M, Savage R, Hancox RJ. . ERJ Open Research. January 2021, 7 (1). PMC 7917232 . PMID 33681344. doi:10.1183/23120541.00801-2020.
↑  Loth DW, Brusselle GG, Lahousse L, Hofman A, Leufkens HG, Stricker BH. . British Journal of Clinical Pharmacology. January 2014, 77 (1): 190–200. PMC 3895360 . PMID 23772842. doi:10.1111/bcp.12181.
↑  Bennett MR, Chang CL, Tuffery C, Hopping S, Hancox RJ. . Respirology. March 2021, 26 (3): 225–232. PMID 33043552. S2CID 222301890. doi:10.1111/resp.13955.
↑  Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R. . Molecular Pharmacology. March 1989, 35 (3): 295–303. PMID 2564629.
1 2 3 4 5  Haeusler G, Schliep HJ, Schelling P, Becker KH, Klockow M, Minck KO,  et al. . Journal of Cardiovascular Pharmacology. 1986, 8 (Suppl 11): S2–15. PMID 2439793. S2CID 24617470. doi:10.1097/00005344-198511001-00002.
↑  Taniguchi T, Ohtani T, Mizote I, Kanzaki M, Ichibori Y, Minamiguchi H,  et al. . Journal of Cardiology. June 2013, 61 (6): 417–422. PMID 23548374. doi:10.1016/j.jjcc.2013.01.009 .
↑  Düngen HD, Apostolovic S, Inkrot S, Tahirovic E, Töpper A, Mehrhof F,  et al. . European Journal of Heart Failure. June 2011, 13 (6): 670–680. PMC 3101867 . PMID 21429992. doi:10.1093/eurjhf/hfr020.
↑  Muresan L, Cismaru G, Muresan C, Rosu R, Gusetu G, Puiu M,  et al.  (PDF). Annales Pharmaceutiques Françaises. September 2022, 80 (5): 617–634  [2023-10-26]. PMID 35093388. S2CID 246428722. doi:10.1016/j.pharma.2022.01.007. （原始内容存档 (PDF)于2024-04-19）.
1 2  Harting J, Becker KH, Bergmann R, Bourgois R, Enenkel HJ, Fuchs A,  et al. . Arzneimittel-Forschung. February 1986, 36 (2): 200–208. PMID 2870720.
↑  Kaumann AJ, Lemoine H. . Naunyn-Schmiedeberg's Archives of Pharmacology. October 1985, 331 (1): 27–39. PMID 2866449. S2CID 22328991. doi:10.1007/bf00498849.
↑  Klockow M, Greiner HE, Haase A, Schmitges CJ, Seyfried C. . Arzneimittel-Forschung. February 1986, 36 (2): 197–200. PMID 2870719.
↑  Manalan AS, Besch HR, Watanabe AM. . Circulation Research. August 1981, 49 (2): 326–336. PMID 6113900. doi:10.1161/01.res.49.2.326 .
↑  Schliep HJ, Schulze E, Harting J, Haeusler G. . European Journal of Pharmacology. April 1986, 123 (2): 253–261. PMID 3011461. doi:10.1016/0014-2999(86)90666-7.
↑  Schliep HJ, Harting J. . Journal of Cardiovascular Pharmacology. 1984, 6 (6): 1156–1160. PMID 6084774. doi:10.1097/00005344-198406060-00024 .
↑  Schnabel P, Maack C, Mies F, Tyroller S, Scheer A, Böhm M. . Journal of Cardiovascular Pharmacology. October 2000, 36 (4): 466–471. PMID 11026647. doi:10.1097/00005344-200010000-00008 .
↑  Smith C, Teitler M. . Cardiovascular Drugs and Therapy. April 1999, 13 (2): 123–126. PMID 10372227. S2CID 12639448. doi:10.1023/A:1007784109255.
↑  Wellstein A, Palm D, Belz GG. . Journal of Cardiovascular Pharmacology. 1986, 8 (Suppl 11): S36–S40. PMID 2439796. S2CID 30987576. doi:10.1097/00005344-198511001-00006.
↑  Bundkirchen A, Brixius K, Bölck B, Nguyen Q, Schwinger RH. . European Journal of Pharmacology. January 2003, 460 (1): 19–26. PMID 12535855. doi:10.1016/S0014-2999(02)02875-3.
↑  Nuttall SL, Routledge HC, Kendall MJ. . Journal of Clinical Pharmacy and Therapeutics. June 2003, 28 (3): 179–186. PMID 12795776. S2CID 58760796. doi:10.1046/j.1365-2710.2003.00477.x.
1 2  Cojocariu SA, Maștaleru A, Sascău RA, Stătescu C, Mitu F, Leon-Constantin MM. . Medicina (Kaunas). February 2021, 57 (2): 155. PMC 7914867 . PMID 33572109. doi:10.3390/medicina57020155 .
↑  . go.drugbank.com.   [2022-08-17]. （原始内容存档于2022-08-17）.
↑  Kirch W, Rose I, Demers HG, Leopold G, Pabst J, Ohnhaus EE. . Clinical Pharmacokinetics. August 1987, 13 (2): 110–117. PMID 2887325. S2CID 25105692. doi:10.2165/00003088-198713020-00003.
↑  Cvan Trobec K, Grabnar I, Kerec Kos M, Vovk T, Trontelj J, Anker SD,  et al. . European Journal of Clinical Pharmacology. July 2016, 72 (7): 813–822. PMID 26996442. S2CID 14146663. doi:10.1007/s00228-016-2041-1.
↑  . Medical Dialogues. 2020-08-22  [2020-08-22]. （原始内容存档于2020-08-09）.
↑  . NHS.   [2024-05-21].
↑  . ratiopharm.   [2024-05-21]. （原始内容存档于2024-06-03）.
Template:Merck Serono
商品名為Zebeta的畢索洛爾片劑，每片劑量5毫克。